Cargando…
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
Rare tumor-specific mutations in patient samples serve as excellent markers to monitor the course of malignant disease and responses to therapy in clinical routine, and improved assay techniques are needed for broad adoption. We describe herein a highly sensitive and selective molecule amplification...
Autores principales: | Chen, Lei, Eriksson, Anna, Weström, Simone, Pandzic, Tatjana, Lehmann, Sören, Cavelier, Lucia, Landegren, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276831/ https://www.ncbi.nlm.nih.gov/pubmed/35821208 http://dx.doi.org/10.1038/s41467-022-31397-y |
Ejemplares similares
-
PB1806: ULTRA-SENSITIVE MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR LEUKEMIA PATIENTS USING SUPERRCA MUTATION ASSAYS WITH FLOW CYTOMETER READOUT
por: Chen, Lei, et al.
Publicado: (2023) -
Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
por: Pandzic, Tatjana, et al.
Publicado: (2022) -
RCA linear integrated circuits /
Publicado: (1970) -
The superdominant RCA with double PDA
por: Mutluoglu, Mesut, et al.
Publicado: (2023) -
P513: MOLECULAR PATTERN BY AGE AND OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY FROM THE SWEDISH AML REGISTRY.
por: Juliusson, Gunnar, et al.
Publicado: (2023)